Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies

por Paramasivan, Poornima, Kankia, Ibrahim H., Langdon, Simon P., Deeni, Yusuf Y.
Publicado 2019

Reversal of doxorubicin resistance in lung cancer cells by neferine is explained by nuclear factor erythroid-derived 2-like 2 mediated lung resistance protein down regulation

por Paramasivan, Poornima, Kumar, Jothi Dinesh, Baskaran, Rathinasamy, Weng, Ching Feng, Padma, Viswanadha Vijaya
Publicado 2020

Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors

por Kankia, Ibrahim H., Paramasivan, Poornima, Elcombe, Matthew, Langdon, Simon P., Deeni, Yusuf Y.
Publicado 2021

Reducing toxic reactive carbonyl species in e-cigarette emissions: testing a harm-reduction strategy based on dicarbonyl trapping

por de Falco, Bruna, Petridis, Antonios, Paramasivan, Poornima, Troise, Antonio Dario, Scaloni, Andrea, Deeni, Yusuf, Stephens, W. Edryd, Fiore, Alberto
Publicado 2020